Vanguard Group Inc Moderna, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 39,562,796 shares of MRNA stock, worth $2.12 Billion. This represents 0.09% of its overall portfolio holdings.
Number of Shares
39,562,796
Previous 39,036,872
1.35%
Holding current value
$2.12 Billion
Previous $4.16 Billion
12.94%
% of portfolio
0.09%
Previous 0.08%
Shares
14 transactions
Others Institutions Holding MRNA
# of Institutions
1,036Shares Held
242MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO42.5MShares$2.27 Billion2.17% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.37 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$804 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$387 Million42.67% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$369 Million0.07% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $20.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...